Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients
Condition(s):HemophiliaLast Updated:March 10, 2016Completed
Hide Studies Not Open or Pending
Condition(s):HemophiliaLast Updated:March 10, 2016Completed
Condition(s):Lupus NephritisLast Updated:January 7, 2020Unknown status
Condition(s):Coronary Heart DiseaseLast Updated:November 10, 2016Unknown status
Condition(s):Hemophilia A and BLast Updated:November 30, 2020Terminated
Condition(s):AtherosclerosisLast Updated:September 29, 2014Terminated
Condition(s):HemophiliaLast Updated:October 22, 2019Withdrawn
Condition(s):HemophiliaLast Updated:December 14, 2022Recruiting
Condition(s):Menstrual Bleeding, HeavyLast Updated:July 20, 2023Recruiting
Condition(s):PneumoniaLast Updated:December 19, 2020Completed
Condition(s):Ovarian Neoplasm EpithelialLast Updated:October 26, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.